SCHEMBL21679527

SCHEMBL21679527

O=C(c1ccc(Sc2ccc(O)cc2)cc1)c1ccc([S+]([O-])c2ccccc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.49
MAPT P10636 3/20 0.49
MEN1 O00255 3/20 0.49
KMT2A Q03164 3/20 0.49
RAB9A P51151 2/20 0.49
HPGD P15428 3/20 0.46
ESR1 P03372 1/20 0.46
ESR2 Q92731 1/20 0.46
PKM P14618 1/20 0.46
HTT P42858 1/20 0.46
SRD5A2 P31213 2/20 0.44
ALDH1A1 P00352 2/20 0.44
NR1H2 P55055 1/20 0.42
CES2 O00748 1/20 0.41
NPC1 O15118 1/20 0.41
LIG1 P18858 1/20 0.40
MAPK1 P28482 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.38
POLB P06746 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7940723 0.87 MEN1 (0.63) LMNAMAPTMEN1KMT2ARAB9A
SCHEMBL8735147 0.84 LMNA (0.56) LMNAMAPTMEN1KMT2ARAB9A
SCHEMBL7938428 0.84 LMNA (0.68) LMNAMAPTMEN1KMT2ARAB9A
SCHEMBL14600281 0.84 LMNA (0.62) LMNAMAPTMEN1KMT2ARAB9A
SCHEMBL8771948 0.82 ALDH1A1 (0.58) LMNAMAPTMEN1KMT2ARAB9A
SCHEMBL7647495 0.82 NR1H2 (0.64) LMNAMAPTMEN1KMT2ARAB9A
SCHEMBL1576927 0.80 ALDH1A1 (0.61) LMNAMAPTMEN1KMT2ARAB9A
SCHEMBL9134344 0.80 LMNA (0.71) LMNAMAPTMEN1KMT2ARAB9A
SCHEMBL4563922 0.80 LMNA (0.71) LMNAMAPTMEN1KMT2ARAB9A
SCHEMBL1128326 0.79 ALDH1A1 (0.55) LMNAMAPTMEN1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109843853-B Composition and method for manufacturing device using the same 东洋合成工业株式会社 2022-09-20 CN disclosed
US-11142495-B2 Composition and method for manufacturing device using same TOYO GOSEI CO., LTD. (JP) 2021-10-12 US disclosed
US-11142495-B2 Composition and method for manufacturing device using same TOYO GOSEI CO., LTD. (JP) 2021-10-12 US disclosed
US-20200048191-A1 COMPOSITION AND METHOD FOR MANUFACTURING DEVICE USING SAME TOYO GOSEI CO., LTD. (JP) 2020-02-13 US disclosed
US-20200048191-A1 COMPOSITION AND METHOD FOR MANUFACTURING DEVICE USING SAME TOYO GOSEI CO., LTD. (JP) 2020-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200048191-A1 COMPOSITION AND METHOD FOR MANUFACTURING DEVICE USING SAME LBR, LMTK2, MMS19 LMNA 85/4885MAPT 750/4885MEN1 3312/4885
US-11142495-B2 Composition and method for manufacturing device using same LBR, LMTK2, MMS19 LMNA 85/4885MAPT 750/4885MEN1 3312/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.